Health Regulatory

What is in scope

Heads of national medical and public-health regulators — the United States Centers for Disease Control and Prevention, the National Institutes of Health, the Food and Drug Administration, the European Medicines Agency, the United Kingdom Medicines and Healthcare products Regulatory Agency, and equivalents.

Why this domain matters

Regulatory agencies sit between political authority and scientific advisory bodies. Their senior leadership is appointed by the executive branch — in some jurisdictions with legislative confirmation, in others without — and their decisions during regulatory crises are among the most consequential government decisions a population encounters in normal life: which drugs reach the market, which mandates apply during an epidemic, which guidance schools and employers are expected to follow.

The dataset's regulatory-medical sub-cluster is one of its tightest. Rochelle Walensky became the first woman CDC Director on 20 January 2021, and was succeeded directly by Mandy Cohen — the second consecutive woman in the role. Monica Bertagnolli became the first permanent woman Director of the National Institutes of Health in November 2023. Janet Woodcock served as Acting Commissioner of the FDA from January 2021 to February 2022, the first woman to lead the agency in any capacity. Across these three institutions, the four first-woman events landed during and immediately after the most consequential public-health regulatory period in modern United States history.

The FDA permanent commissionership remains a position no woman has held; tracked on the counterexamples page.